Pfizer has created a cure for COVID-19: how it works and when it goes on sale
Pfizer is beginning a global Phase 2/3 study of EPIC-PEP of a new oral antiviral drug against COVID-19 for post-exposure prophylaxis in adults, the pharmaceutical company reported on the official website of the pharmaceutical company. EPIC-PEP (Evaluation of COVID-19 Protease Inhibition in Post-Exposure Prophylaxis) is the third study launched as part of this global...
'Increases protection tenfold': Johnson & Johnson urges Americans to re-inject their vaccine
Johnson & Johnson said that if you get an extra dose of its COVID-19 vaccine, it will significantly increase protection against the coronavirus, NPR said. According to recent research from a pharmaceutical company, people who receive a booster shot with Johnson & Johnson vaccine are better protected ...